The AS Holding group became the largest individual owner of BOSNALIJEK DD Sarajevo, after the processing process was successfully completed and more than 37 percent of shares.
Thus, AS Holding achieved a decisive influence in the largest pharmaceutical company in Bosnia and Herzegovina.
– Bosnalijek is a company built on trust, knowledge and quality. Our goal is to fully support its further development through stability, responsible attitude towards markets and partners. This is not just a business decision – this is the strategic step in which we want to confirm that domestic companies can build strong and competitive systems in the European market – said Rusmir Hrvić, President of the Management Board as Holding.
Bosnalijek currently operates in more than 20 international markets, with representative offices and branches in the region and the European Union. Its portfolio includes numerous medicines, brands and licenses, and the company has its own research and development capacities.
The acquisition of Bosnalijek is one of the most important transactions in the domestic business sector in the last decade, and its importance is also reflected in the message that domestic investors take responsibility for key industries, invest their sustainability and open space for long-term development. AS holding remains dedicated to the principles of sustainable growth, transparency and social responsibility, and believes that Bosnalijek is the potential symbol that Bosnia and Herzegovina has high-value added industries.
– We are convinced that Synergy between Bosnalijek and AS holding will contribute to the development of a stronger domestic pharmaceutical sector, but also the broader recognition of Bosnia and Herzegovina and products on the international market – the ZABUBUR ZUBUR, PR AS HOLDING, reports Avaz.
